Diagnostics and devices play stronger hand at Chugai Pharmaceutical
This article was originally published in Clinica
Executive Summary
Chugai Pharmaceutical (Japan) has reported an 11.3% rise in diagnostics sales in 1994. Turnover in the division reached ¥,900 million ($91 million), says the company, and was led by sales of DNA probes and enzyme-immunoassay diagnostic systems. Chugai launched its DNA probe for tuberculosis diagnosis in May 1994.